Navigation Links
U.S. FDA Approves Bayer's Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System
Date:3/14/2011

WAYNE, N.J., March 14, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration has approved Gadavist™ (gadobutrol) Injection, a macrocyclic gadolinium-based contrast agent (GBCA), for intravenous use in diagnostic magnetic resonance imaging (MRI) in adults and children (2 years of age and older) to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system (CNS).  

Gadavist is formulated at a higher concentration (1 mmol/mL) compared to certain other GBCAs.  Compared to 0.5 molar gadolinium-based contrast agents, the higher concentration of Gadavist results in half the volume of administration and a more compact contrast bolus.  It is important to closely examine the dosing table in the full prescribing information to determine the volume of Gadavist to be administered.

"The approval of Gadavist enriches our strong portfolio of MRI contrast media and provides a new option for U.S. healthcare providers in contrast-enhanced imaging of the CNS," said John Rotondo, Vice President, Commercial Operations, Bayer HealthCare Pharmaceuticals.  "Our MR contrast agents are some of the most widely used today, and Bayer is proud to be a world leader in diagnostic imaging."IMPORTANT SAFETY INFORMATIONWARNING: NEPHROGENIC SYSTEMIC FIBROSIS (NSF)Gadolinium-based contrast agents (GBCAs) increase the risk for NSF among patients with impaired elimination of the drugs. Avoid use of GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other modalities. NSF may result in fatal or debilitating fibrosis affecting the skin, muscle and internal organs.

  • The risk for NSF appears highest among patients with:
  • Chronic, severe kidney disease (GFR < 30 mL/min/1.73m(squared)), or
  • Acute kidney i
    '/>"/>

  • SOURCE Bayer HealthCare Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
    2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
    3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
    4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
    5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
    6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
    7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
    8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
    9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
    10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
    11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
    (Date:8/28/2014)... , August 28, 2014 ... titled, "DNA diagnostics Market (products, applications, techniques, end ... Opportunities, Growth and Forecast, 2013 - 2020," indicates ... $19 billion by 2020 registering a CAGR of ... provide accurate diagnosis and cost effectiveness over alternative ...
    (Date:8/28/2014)... Aug. 28, 2014 /PRNewswire-iReach/ -- Gateway Analytical announced ... 9 th Annual Global Pharma Manufacturing Summit ... 8-9 th . The Global Pharma Manufacturing Summit ... small molecule and biologic pharmaceutical manufacturing. The conference ... today,s manufacturers face, such as the increasing pressure ...
    Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
    ... Lloydspharmacy, the community pharmacy chain, has revealed that one in ... million** adults - has taken or applied medicines which they later ... more than half (53%) of people do not always check the ... a family member. This is worrying considering that ...
    ... 2011 ORFLO Technologies announced the international launch of ... automated cell counter at the American Association for Cancer ... http://photos.prnewswire.com/prnh/20110403/SF76326 ) "The Moxi Z ... cell counting community," said Manju Sethi, Vice President of ...
    Cached Medicine Technology:Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3ORFLO Launches First Hands-free Mini Automated Cell Counter 2
    (Date:8/29/2014)... (PRWEB) August 29, 2014 ALS, more commonly ... that damages the motor neurons in the brain and spinal ... the nerve cells controlling movement are harmed, which causes the ... this leads to death. , ALS is a disease that ... as many as 30,000 Americans have the disease at any ...
    (Date:8/29/2014)... Canadian Healthy Vending , the largest ... annual survey of its 200 operators from every region ... that appeal to Canadian consumer seeking refreshment at healthy ... top five selling healthy snacks and top five selling ... issue for consumers, employers, and families. Everyone wants to ...
    (Date:8/29/2014)... (PRWEB) August 29, 2014 Until now, ... (relational tables) or unstructured data (document stores). SQL products ... products have basically managed the wide assortment of unstructured ... to work with Big Data is with a NoSQL ... the various aspects of all Big Data issues. ...
    (Date:8/28/2014)... August 29, 2014 VPS (Virtual ... physical server computer into many servers, each of ... on someone’s own dedicated computer. Top10BestSEOHosting.com has recently ... that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ), Bluehost and IX ... in 2014. , The IT manager of Top10BestSEOHosting.com ...
    (Date:8/28/2014)... York (PRWEB) August 29, 2014 New ... they will be traveling around the country to Log ... final show in November. The New Energy Works team ... their timber frame design and build expertise, project images, ... Drake Ambrosino , New Energy Works’ Mid-West Representative, will ...
    Breaking Medicine News(10 mins):Health News:Charity Event to Raise Awareness and Donations for the ALS Foundation 2Health News:Survey Results: What Products Do Canadians Want in Their Healthy Vending Machines? 2Health News:Survey Results: What Products Do Canadians Want in Their Healthy Vending Machines? 3Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 3Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 4Health News:Top10BestSEOHosting.com Announces The Best Three VPS Hosting Suppliers 2Health News:New Energy Works Timberframers Prepares to Exhibit Timber Framing at Autumn Trade Shows 2Health News:New Energy Works Timberframers Prepares to Exhibit Timber Framing at Autumn Trade Shows 3
    ... In January, victorious,politicians will go to work on America,s ... patients don,t have to wait on their elected,officials to ... give,feedback directly to their doctors, according to patient satisfaction ... "We don,t know whether politicians listen to their ...
    ... Nov. 24 After diabetes and hypertension,renal artery stenosis ... the opinions of nephrologists and cardiologists, as well as ... to screen for it. , ... cerebrovascular,cardiac, and peripheral arterial disease increases the frequency of ...
    ... 24 These days, many are feeling,financially, emotionally and ... under your eyes. Feeling spiritual seems the farthest thing,from ... smartphones, and online social,networking sites, we remain connected 24/7, ... mentally and physically is the new ,old, trend?,Join the ...
    ... job seekers find each other easier, Fresho.com becomes a job search engine ... ... (PRWEB) November 24, 2008 -- Due to the current economic woes, employment ... searches. To cope with the increasing demand for new job openings, Fresho ...
    ... of the elderly, the golden years are anything but. ... a spouse or loved one, many adults 65 years and ... help this group understand and treat the problem, another group ... , "Centenarians are still rare, and depression hasn,t been studied ...
    ... Shows Network Evening News and Newspapers Devote More Coverage to ... , , Health Was the ... Primary Season , , WASHINGTON, ... period of upheaval and transformation, a study from the Kaiser ...
    Cached Medicine News:Health News:Politicians May Not Listen ... But Doctors Do, Says DrScore 2Health News:When Is Screening for Renal Artery Stenosis Medically Necessary? 2Health News:Engaging In Life with One Spirit Book Club 2Health News:Fresho.com Adapts As The Online Recruiting Market Heats Up 2Health News:Bittersweet milestones 2Health News:Wide-Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 2Health News:Wide-Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 3Health News:Wide-Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 4
    ... research model of the Bowman Perfusion Monitor ... continuously in real-time. This precision instrument activates ... which is connected by an umbilical cord ... digital form and send the data to ...
    Housed in a small lightweight, flame retardant plastic cases, meters are equipped with a convenient multiposition handle/stand. Measure microcirculation in 1 cubic mm of tissue for real-time assessme...
    ... featured laser doppler system for continuous ... multiple tissue sites. This latest generation ... Processing (DSP) and laser Doppler flowmetry ... to use, multi-channel monitor, setting new ...
    Transcranial vascular DWL doppler....
    Medicine Products: